silicone rubber compound injection and tissue harvest to assess vessel dilatation in neurodegenerative diseases

Dolichoectasia:血管性認知症とアルツハイマー病

Microvascular endothelial cells that line the cerebral capillaries are the main components for forming the blood-brain barrier (BBB)1 which plays a crucial role in regulating what enters or leaves the brain circulation with the periphery. Essential nutrients needed for nervous tissue are permitted to enter the BBB, while some essential amino acids like glutamate are expelled from the brain, as high concentrations can cause permanent neuroexcitatory damage to brain tissue2. Under normal physiological conditions, the BBB limits the amount of plasma proteins like albumin3,4 and prothrombin from entering the brain since those can have detrimental effects5,6,7. Finally, the BBB protects the brain from neurotoxins that are circulating in the periphery, such as xenobiotics from food or the environment1. Overall, damage to brain tissues is irreversible, and aging that correlates with low levels of neurogenesis8 highlights the importance of the BBB in protecting and preventing any factors from accelerating the neurodegenerative process.
In dolichoectasia (or large blood vessel dilatation), a decrease in vessel elasticity is observed, which results in vessels undergoing morphological changes, thus rendering them dysfunctional9 and leading to reduced blood flow in the brain. This reduction in blood flow subsequently diminishes oxygen and glucose supply, ultimately triggering damage to the BBB through the activation of reactive astrocytes10. When the internal elastin lamina of vessels is damaged from dolichoectasia11, repeated stimulation of the vascular endothelial growth factor (VEGF) is necessary for angiogenesis. This can lead to the formation of leaky vessels and ultimately result in pathological angiogenesis, characterized by the development of defective vessels12. During pathological angiogenesis, when blood vessels become defective, a compensatory mechanism appears to restore vessel integrity by upregulating tight junction proteins. However, this process can inadvertently disrupt the BBB when the structural integrity of a blood vessel is lost13. This may occur through further disrupting the BBB and promoting the production of amyloid plaque14. Additionally, leakage from the periphery can cause neuroinflammation15, which results in neuronal degeneration and subsequent memory loss.
Structurally the protection that the BBB provides is through the tight junctions that prevent xenobiotic agents from the blood entering the brain. When permitting certain substances to enter the brain, the BBB mainly does it through two major processes, passive diffusion, or specific channels (like ion channels and transporters)1. In AD, research has demonstrated that a dysfunctional vascular system plays a significant role in the progression of the condition12,13. The formation of amyloid-beta (A&#946;) plaques and neurodegeneration can result from the breakdown of the BBB12,13 and disturbances in cerebral blood flow16. A reduction in cerebral blood flow can be seen in elderly individuals diagnosed with vascular dementia and AD17,18. Damage to the blood-brain barrier (BBB) along with a dysfunctional cerebral blood flow (CBF) can contribute to the increased production of A&#946; concentration in the brain, accompanied by the infiltration of foreign materials from the peripheral circulation19.
To investigate the pathogenesis of neurological diseases like AD and vascular dementia (VaD), models are developed to replicate the disease. In vitro models are extensively used but lack the biological environment for extensive disease modeling like mixed cell population, thus necessitating the importance of in vivo models. Mice are commonly used due to their ease of genetic manipulation in generating human-like properties (e.g., pathology) in disease. With the progression that has been made so far, there is still a continued need for improved models to emulate disease phenotypes like large vessel dilatation and their role in AD. To this end, we saw an opportunity and modified a technique that involved the injection of elastase into the Cisterna magna of mice20,21. Elastase is an enzyme that has been shown to break down elastin in connective tissue22 and in surrounding tight junctions23. The Cisterna magna was chosen as the point of injection due to it being located directly above the circle of Willis, the largest blood vessel in the brain. By injecting elastase into the Cisterna magna, we can compromise the BBB and blood vessels by breaking down the tight junctions and inducing dilatation of blood vessels (circle of Willis)24,25. Combining this technique with the use of an AD mouse model of pathology, for improved understanding of the pathogenesis for the vascular component of AD, can provide valuable insights into the complex interactions and influences between these two distinct pathologies.
Previous studies have demonstrated instances where patients display both the pathological features of AD and VaD, a condition typically referred to as mixed dementia26,27. Thus, understanding the interconnected mechanisms between both conditions can offer a more comprehensive perspective on the progression and manifestation of these neurodegenerative disorders, enhances our comprehension of the underlying mechanisms and potential therapeutic strategies. To this end, we demonstrate the application of elastase in an AD pathology mouse model (AppNL-F) to identify vascular changes.

著者スポットライト:トランスジェニックマウスにおけるアルツハイマー病への血管寄与のモデリング

マウスのドリコ拡張症を誘発するための視覚的アプローチによる大血管媒介性脳血管機能障害のモデル化

The scope of our research is the model dolichoectasia in a transgenic mouse model to see the maximum impact that vascular changes have on Alzheimer's disease pathology. We are able to show that a single dose of elastase injection into the Cisterna magna of mice is able to cause dilatation up to the three months. Not much is known about individuals who suffer from both vascular dementia and Alzheimer's disease.We hope to bridge this gap by causing vascular changes in these transgenic mouse model to try and understand the pathogenesis of this form of mixed dementia. Previous studies were able to show that dilatation lasts up to two weeks, in our study, we showed that dilatation lasts up to three months with a low mortality during our surgical procedure. Successful dilatation of large blood vessel in a transgenic mouse model provides us with the opportunity to test drugs to prevent or improve vascular changes in Alzheimer's disease.

神経変性疾患における血管拡張を評価するためのシリコーンゴムコンパウンド注射と組織採取

silicone-rubber-compound-injection-tissue-harvest-to-assess-vessel

Research

JoVE Journal

Neuroscience

Silicone Rubber Compound Injection and Tissue Harvest to Assess Vessel Dilatation in Neurodegenerative Diseases

51 ビュー. まず、麻酔をかけたマウスを吸収パッドまたはおむつの上に置きます。マウスのつま先をつまんで、反射が止まったことを確認します。サージカルテープを使用して、胸腔を上に向けてすべての手足を固定します。ピンセットやハサミを使い、胸腔を丁寧に開けて心臓を露出させます。23ゲージの鈍い針を心臓の左心室に挿入して灌流しま?...

ビデオ: 神経変性疾患における血管拡張を評価するためのシリコーンゴムコンパウンド注射と組織採取

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction

The blood-brain (BBB) is a crucial system that regulates selective brain circulation with the periphery, as an example, allowing necessary nutrients to enter and expel excessive amino acids or toxins from the brain. To model how the BBB can be compromised in diseases like vascular dementia (VaD) or Alzheimer's disease (AD), researchers developed novel methods to model vessel dilatation. A compromised BBB in these disease states can be detrimental and result in the dysregulation of the BBB leading to untoward and pathological consequences impacting brain function. We were able to modify an existing technique that enabled us to inject directly into the Cisterna magna (CM) to induce dilatation of blood vessels using elastase, and disrupt the tight junctions (TJ) of the BBB. With this method, we were able to see various metrics of success over previous techniques, including consistent blood vessel dilatation, reduced mortality or improved recovery, and improving the fill/opacifying agent, a silicone rubber compound, delivery for labeling blood vessels for dilatation analysis. This modified minimally invasive method has had promising results, with a 19%-32% increase in sustained dilatation of large blood vessels in mice from 2 weeks to 3 months post-injection. This improvement contrasts with previous studies, which showed increased dilatation only at the 2 week mark. Additional data suggests sustained expansion even after 9.5 months. This increase was confirmed by comparing the diameter of blood vessels of the elastase and the vehicle-injected group. Overall, this technique is valuable for studying pathological disorders that affect the central nervous system (CNS) using animal models.

We demonstrate chemically inducing large blood vessel dilatation in mice as a model for investigating cerebrovascular dysfunction, which can be used for vascular dementia and Alzheimer's disease modeling. We also demonstrate visualizing the vasculature by injecting silicone rubber compound and providing clear visual guidance for measuring changes in blood vessel size.

The blood-brain (BBB) is a crucial system that regulates selective brain circulation with the periphery, as an example, allowing necessary nutrients to ...

神経科学

Mouse Cisterna Magna (CM) Injection Procedure to Study Elastase-Induced Vessel Dilatation in CNS Disorders

To begin place an anesthetized mouse on a fresh surgical drape. Apply ophthalmic ointment to the animal's eye to prevent dryness, then inject Metacam, followed by 0.5 milliliters of saline subcutaneously into the mouse. Shave the neck of the mouse at the base of the occipital bone, and wipe down the surface with sterile PBS.Transfer the mouse to the stereotaxic frame in the prone position. Place the nose bar from the stereotaxic frame on top of the mouse to provide stability, and ensure the upper teeth are fastened. Position the animal head at a 120 degree angle from the body to elevate and distend the nape.Next, using sterile gauze, clean the surgical site three times with Betadine scrub and 70%ethanol. Then wipe once with Betadine solution. Using a scalpel, make a small one centimeter incision.Carefully run the scalpel along the midline to cut through the muscles. Using forceps, gently pull the muscles apart to the left and the right. Then load the Hamilton syringe with 2.5 microliters of elastase avoiding air bubbles.Slowly insert the syringe with the bevel facing upward into the center of the cisterna magna. After puncturing, carefully withdraw the bevel to facilitate the release of a small amount of cerebrospinal fluid or CSF. Next, reinsert the bevel to the puncture site and slowly inject elastase or vehicle into the cisterna magna, leaving the needle in place for one minute to prevent elastase leakage.After removing the bevel, close the incision site with a non-absorbable surgical suture, and turn off the anesthetic. Remove the animal from the stereotaxic frame and place it on a 37 degree Celsius heat pad until the mouse recovers.

CNS障害におけるエラスターゼ誘発血管拡張を研究するためのマウスCisterna Magna(CM)注射手順

To begin, place the anesthetized mouse on an absorbent pad or diaper. Pinch the mouse toe to confirm the ceased reflexes. Using surgical tape, secure all limbs with the chest cavity facing upward.Employing tweezers and scissors, carefully open the chest cavity to expose the heart. Insert a 23 gauge blunt needle into the left ventricle of the heart for perfusion. Then mix five milliliters of silicone rubber compound solution, with five milliliters of the diluent in a 50 milliliter tube.Using a hose linked 23 gauge blunt needle, inject 10 milliliters of the mixed compound into the heart. Next day using fine tweezers, gently remove the skull of the mouse and place the extracted brain in 4%paraformaldehyde at room temperature. After a 24 hour incubation, wash the brain three times in PBS and store it in 30%sucrose at four degrees Celsius.Pictographs of brains illustrated the enlargement of the basala artery and increased tortuosity around the circle of Willis following elastase injection compared with the PBS control group. Compared to the control group treated with PBS a significant blood vessel dilation was observed following a single elastase injection into the cisterna magna of three month old mice, which sustained for three months.